SGHT - NASDAQ

Sight Sciences, Inc.

SGHT·NASDAQ

$4.34

-4.4%

HealthcareMedical - Devices

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$236.14M

EPS-0.7400

P/E Ratio-5.86

Earnings Date08/06/2026

sght

Revenue

Last Annual Value

77.36M

3-Year CAGR

5-Year CAGR

23%

10-Year CAGR

26%

Adjust for Inflation

Sight Sciences, Inc. Competitors Analysis of Revenue

SGHT · NASDAQ

Company	Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sight Sciences, Inc. NASDAQ:SGHT	77.36M	-1.5%	9.6%	N/A
Owens & Minor, Inc. NYSE:OMI	10.70B	1.2%	1.8%	1.0%
Forte Biosciences, Inc. NASDAQ:FBRX	0.00	N/A	N/A	N/A
Hyperfine, Inc. NASDAQ:HYPR	13.56M	7.1%	55.4%	N/A
MaxCyte, Inc. NASDAQ:MXCT	33.03M	-7.2%	-0.5%	10.4%
Owlet, Inc. NYSE:OWLT	105.70M	25.1%	6.9%	N/A
Rapid Micro Biosystems, Inc. NASDAQ:RPID	33.59M	14.3%	7.7%	N/A
TriSalus Life Sciences, Inc. NASDAQ:TLSI	45.15M	34.6%	40.0%	N/A
908 Devices Inc. NASDAQ:MASS	56.20M	3.8%	5.9%	N/A
Senseonics Holdings, Inc. NASDAQ:SENS	35.26M	16.3%	20.9%	59.4%
CVRx, Inc. NASDAQ:CVRX	56.65M	13.0%	34.2%	N/A

Sight Sciences, Inc. Fair Value Envelope

SGHT · NASDAQ

Our analysis suggests that SGHT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.34, this represents a potential HIDDEN relative to our calculated worth for Sight Sciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $4.34

Related Guides

Blog Categories

Continue your SGHT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.